Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas.
OBJECTIVE
A recent clinical report demonstrated that topical nerve growth factor (NGF) treatment in patients affected by corneal neurotrophic ulcers induced epithelial and stromal healing restoring corneal integrity. Mechanisms(s) undergoing these clinical NGF actions are still unclear. The aim of this study was to investigate the role of NGF in human and rat cornea physiopathology.


METHODS
Expression of high-affinity NGF receptors, NGF-mRNA, and NGF protein was evaluated in human and rat normal corneas, in human and rat corneal epithelial cell cultures, in human corneal organ culture, and in the rat cornea after an experimental model of epithelial injury, by means of immunohistochemistry, in situ hybridization reverse transcription-polymerase chain reaction, and enzyme-linked immunosorbent assay.


RESULTS
The resultant data demonstrated that NGF is a constitutive molecule present and produced in normal human and rat corneas. In vitro human and rat corneal epithelial cells produce, store, and release NGF and also express high-affinity NGF receptors (TrkA). In human organ culture, epithelium, keratocytes, and endothelium have been shown to bind exogenous radiolabeled NGF, and the epithelial cells' binding was increased after epithelium injury. In vivo, after rat corneal epithelial injury, a transient increase of corneal NGF levels was observed. Inhibition of endogenous NGF activity by neutralizing anti-NGF antibodies delayed the corneal epithelial healing rate, whereas exogenous administration of NGF accelerated healing.


CONCLUSIONS
Taken together, the above findings show that NGF plays an important role in corneal physiopathology and suggest that this neurotrophin may exert therapeutic action in wide-spectrum corneal diseases.
Lambiase
A
A
Department of Ophthalmology, University of Rome Tor Vergata, National Research Council, Italy.
Manni
L
L
Bonini
S
S
Rama
P
P
Micera
A
A
Aloe
L
L
D000368:Aged; D000818:Animals; D002057:Burns, Chemical / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D003315:Cornea / Q000378:metabolism / Q000503:physiopathology; D065306:Corneal Injuries; D019573:Epithelium, Corneal / Q000378:metabolism; D005126:Eye Burns / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D005131:Eye Injuries / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D017403:In Situ Hybridization; D008297:Male; D008875:Middle Aged; D020932:Nerve Growth Factor / Q000494:pharmacology / Q000502:physiology*; D009924:Organ Culture Techniques; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D020917:Receptor, trkA / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology*
D012333:RNA, Messenger; D020932:Nerve Growth Factor; D020917:Receptor, trkA